欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/H/0110/001
药品名称
Femara
活性成分
Letrozole 2.5 mg
剂型
Coated tablet
上市许可持有人
NOVARTIS 8-10 Rue Henri Sainte Claire Deville Rueil Malmaison 92500 France
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Croatia (HR)
Femara 2,5 mg filmom obložene tablete
United Kingdom (Northern Ireland) (XI)
Norway (NO)
Latvia (LV)
Lithuania (LT)
Femara 2,5mg plėvele dengtos tabletės
Hungary (HU)
FEMARA 2,5 mg filmtabletta
Estonia (EE)
Bulgaria (BG)
Cyprus (CY)
Romania (RO)
Femara 2,5 mg comprimate filmate
Slovak Republic (SK)
Slovenia (SI)
Malta (MT)
Germany (DE)
Belgium (BE)
Luxembourg (LU)
Ireland (IE)
Austria (AT)
Femara 2,5 mg - Filmtabletten
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (EL)
Finland (FI)
许可日期
1996/12/06
最近更新日期
2025/12/02
药物ATC编码
L02BG Aromatase inhibitors
申请类型
TypeLevel1:
TypeLevel2:
TypeLevel3:
TypeLevel4:
TypeLevel5:
附件文件下载
Final Product Information
|
2025_02_28_Femara PI _ QRD update _ RSI response _ Final clean
Date of last change:2025/04/07
Final SPC
|
Day30_TypeIA_femara
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase